|
WDR33 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.10490000043906E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94220000000667E-05 |
| Normal-vs-Stage2 |
2.85600000315966E-08 |
| Normal-vs-Stage3 |
7.43560000016075E-07 |
| Normal-vs-Stage4 |
3.68780000000735E-05 |
| Stage1-vs-Stage2 |
2.141100E-03 |
| Stage1-vs-Stage3 |
8.154100E-02 |
| Stage1-vs-Stage4 |
4.288000E-01 |
| Stage2-vs-Stage3 |
1.096760E-01 |
| Stage2-vs-Stage4 |
3.342000E-02 |
| Stage3-vs-Stage4 |
4.818000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.69259999974692E-07 |
| Normal-vs-AfricanAmerican |
1.678220E-01 |
| Normal-vs-Asian |
8.01770000000701E-05 |
| Caucasian-vs-AfricanAmerican |
5.128500E-02 |
| Caucasian-vs-Asian |
9.029600E-01 |
| AfricanAmerican-vs-Asian |
6.577700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51190000000179E-06 |
| Normal-vs-Female |
7.38000000000127E-07 |
| Male-vs-Female |
9.598000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.413800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.10090000016561E-07 |
| Normal-vs-Age(61-80Yrs) |
1.14849999954814E-07 |
| Normal-vs-Age(81-100Yrs) |
1.019110E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.513900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.201810E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.298200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.020200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.219400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.214800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.955800E-02 |
| Classical-VS-Follicular |
1.120240E-02 |
| Classical-VS-Other |
5.589600E-01 |
| Classical-VS-Normal |
3.52820000000253E-05 |
| Tall-VS-Follicular |
7.414200E-01 |
| Tall-VS-Other |
1.462780E-01 |
| Tall-VS-Normal |
5.96859999999477E-05 |
| Follicular-VS-Other |
2.144800E-01 |
| Follicular-VS-Normal |
2.01239999997327E-06 |
| Other-VS-Normal |
2.824200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.89680004614968E-09 |
| Normal-vs-N1 |
2.588600E-04 |
| N0-vs-N1 |
4.122800E-01 |
|
|
